Quantcast

Latest George Wilding Stories

2011-03-30 11:30:00

MENLO PARK, Calif., March 30, 2011 /PRNewswire/ -- The best way to prevent the lethal spread of prostate cancer is by stopping cancer cell invasion of other tissues. Available treatments such as chemotherapy are toxic and can often be risky for older men, who are also most likely to get prostate cancer. In response, researchers from SRI International have identified a drug candidate that shows promise stopping both prostate cancer growth and cancer cell invasion. Early studies show that...

2010-11-10 07:00:00

HOUSTON, Nov. 10, 2010 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc., a company developing novel therapies that can be precisely controlled after delivery, today announced the appointment of four new members to its Clinical Advisory Board (CAB). The new appointments enhance the range and depth of expertise of the CAB, which provides medical and strategic guidance for the company's product development and commercialization activities that include two programs in clinical trials. The...

2010-09-10 20:58:00

LOS ANGELES, Sept. 10 /PRNewswire/ -- Dean Ornish MD, recognized for establishing the impact of diet on prostate cancer (and heart disease), along with over a dozen internationally recognized prostate cancer experts will meet with over 800 prostate cancer survivors and their significant others at the Los Angeles Marriott near LAX on September 11th and 12th to discuss the latest thinking on prostate cancer treatment. Topics to be covered are lifestyle and diet, immune therapy, active...

2009-10-09 14:23:00

PHILADELPHIA, Oct. 9 /PRNewswire-USNewswire/ -- The Sbarro Health Research Organization (www.shro.org) at Temple University has launched the Columbus Cancer Foundation (www.columbuscancerfoundation.org), a nonprofit organization that will raise funds for joint American and European educational initiatives, basic and clinical cancer research and international scientific collaboration. The name was chosen in honor of the courage and conviction with which Christopher Columbus embarked...

2008-10-22 09:00:10

Pfizer announced today that it has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr. Rothenberg comes to Pfizer from Vanderbilt where he was Professor of Medicine at the Vanderbilt University Medical Center and Ingram Professor of Cancer Research at the Vanderbilt-Ingram Cancer Center. In his new role, Dr. Rothenberg will be responsible for overseeing clinical research and development activities as well...

2008-10-21 12:00:08

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, and the University of Michigan today announced an agreement on the commercial development of prostate cancer diagnostics. The agreement puts in place a number of activities to help progress Metabolon's Prostarix(TM) line of prostate cancer diagnostics including an exclusive license for Metabolon to use prostate cancer aggressitivity markers that were discovered in a collaborative research project between...

2008-09-11 18:00:36

SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the "Company" or "Pharmacyclics") announced today that Christine A. White, M.D., Richard M. Levy Ph.D., Mr. Miles R. Gilburne and Richard A. Miller, M.D. have resigned as members of the Board of Directors of the Company, effective immediately. The remaining members of the Board of Directors, consisting of Mr. Robert W. Duggan and Mr. James L. Knighton, appointed Minesh Mehta, M.D. and Glenn C. Rice, Ph.D. to the...

2008-08-19 09:01:12

Advanced Cancer Therapeutics, LLC (ACT) announced today that industry veteran Gilles H. Tapolsky, Ph.D. has joined ACT as chief scientific officer. Dr. Tapolsky brings over 20 years of experience in corporate management, research and pharmaceutical development to ACT. In this newly created position, he will be responsible for the leadership of all pre-clinical and clinical development activities. "We are thrilled to have Gilles join our team. He has led a distinguished career in...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.